(+)-catechin multiple interactions ISO RGD:1319302 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PPP1R3C mRNA CTD PMID:24763279 (1->4)-beta-D-glucan multiple interactions ISO RGD:1319303 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP1R3C mRNA CTD PMID:36331819 (S)-amphetamine increases expression ISO RGD:1319303 6480464 Dextroamphetamine results in increased expression of PPP1R3C mRNA CTD PMID:19194377 1,2-dichloroethane decreases expression ISO RGD:1319303 6480464 ethylene dichloride results in decreased expression of PPP1R3C mRNA CTD PMID:28960355 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of PPP1R3C mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of PPP1R3C mRNA CTD PMID:17351261 17beta-estradiol multiple interactions ISO RGD:1319302 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPP1R3C mRNA, [Estradiol co-treated with TGFB1 protein] results in increased expression of PPP1R3C mRNA CTD PMID:19619570 , PMID:30165855 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPP1R3C mRNA CTD PMID:35192832 17beta-estradiol decreases expression ISO RGD:1319302 6480464 Estradiol results in decreased expression of PPP1R3C mRNA CTD PMID:19619570 more ... 2,2',5,5'-tetrachlorobiphenyl increases expression EXP 6480464 2 more ... CTD PMID:23829299 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319302 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPP1R3C mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP1R3C mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1319303 6480464 Tetrachlorodibenzodioxin results in increased expression of PPP1R3C mRNA CTD PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1319303 6480464 Tetrachlorodibenzodioxin affects the expression of PPP1R3C mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1319303 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPP1R3C mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to PPP1R3C gene] CTD PMID:25975270 , PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3C mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319302 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3C mRNA CTD PMID:19619570 , PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1319303 6480464 Tetrachlorodibenzodioxin results in decreased expression of PPP1R3C mRNA CTD PMID:19933214 more ... 2-hydroxypropanoic acid decreases expression ISO RGD:1319302 6480464 Lactic Acid results in decreased expression of PPP1R3C mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1319302 6480464 beta-methylcholine affects the expression of PPP1R3C mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-diaminodiphenylmethane decreases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in decreased expression of PPP1R3C mRNA CTD PMID:25380136 4,4'-sulfonyldiphenol increases expression ISO RGD:1319303 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPP1R3C mRNA CTD PMID:30951980 4-hydroxyphenyl retinamide decreases expression ISO RGD:1319302 6480464 Fenretinide results in decreased expression of PPP1R3C mRNA CTD PMID:15958647 5-aza-2'-deoxycytidine multiple interactions ISO RGD:1319302 6480464 [[Decitabine co-treated with trichostatin A] affects the methylation of PPP1R3C promoter] which affects the expression of PPP1R3C mRNA CTD PMID:18803327 7,12-dimethyltetraphene decreases expression ISO RGD:1319303 6480464 9 more ... CTD PMID:32553695 8-Br-cAMP increases expression ISO RGD:1319302 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of PPP1R3C mRNA CTD PMID:20147733 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of PPP1R3C mRNA CTD PMID:31881176 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of PPP1R3C mRNA CTD PMID:28959563 aflatoxin B1 affects expression ISO RGD:1319302 6480464 Aflatoxin B1 affects the expression of PPP1R3C protein CTD PMID:20106945 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of PPP1R3C mRNA CTD PMID:33354967 aflatoxin B1 decreases methylation ISO RGD:1319302 6480464 Aflatoxin B1 results in decreased methylation of PPP1R3C gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO RGD:1319302 6480464 Aflatoxin B1 results in decreased expression of PPP1R3C mRNA CTD PMID:27153756 all-trans-retinoic acid decreases expression ISO RGD:1319302 6480464 Tretinoin results in decreased expression of PPP1R3C mRNA CTD PMID:16249480 all-trans-retinoic acid multiple interactions ISO RGD:1319303 6480464 [bisphenol A co-treated with Tretinoin] results in increased expression of PPP1R3C mRNA CTD PMID:30951980 all-trans-retinoic acid increases expression ISO RGD:1319302 6480464 Tretinoin results in increased expression of PPP1R3C mRNA CTD PMID:23724009 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of PPP1R3C mRNA CTD PMID:30779732 antirheumatic drug increases expression ISO RGD:1319302 6480464 Antirheumatic Agents results in increased expression of PPP1R3C mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO RGD:1319302 6480464 aristolochic acid I results in decreased expression of PPP1R3C mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:1319303 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PPP1R3C mRNA CTD PMID:15894712 arsenite(3-) decreases expression ISO RGD:1319303 6480464 arsenite results in decreased expression of PPP1R3C mRNA CTD PMID:15894712 atazanavir sulfate multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 atrazine increases expression ISO RGD:1319302 6480464 Atrazine results in increased expression of PPP1R3C mRNA CTD PMID:22378314 avobenzone decreases expression ISO RGD:1319302 6480464 avobenzone results in decreased expression of PPP1R3C mRNA CTD PMID:31016361 azathioprine decreases expression ISO RGD:1319302 6480464 Azathioprine results in decreased expression of PPP1R3C mRNA CTD PMID:22623647 benzo[a]pyrene multiple interactions ISO RGD:1319303 6480464 [arsenite co-treated with Benzo(a)pyrene] results in decreased expression of PPP1R3C mRNA, AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of PPP1R3C mRNA] CTD PMID:15034205 , PMID:15894712 benzo[a]pyrene increases methylation ISO RGD:1319302 6480464 Benzo(a)pyrene results in increased methylation of PPP1R3C 3' UTR more ... CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1319302 6480464 Benzo(a)pyrene results in decreased expression of PPP1R3C mRNA CTD PMID:21632981 more ... benzo[a]pyrene decreases expression ISO RGD:1319303 6480464 Benzo(a)pyrene metabolite results in decreased expression of PPP1R3C mRNA, Benzo(a)pyrene results in decreased expression of PPP1R3C mRNA CTD PMID:15034205 more ... benzo[a]pyrene increases expression ISO RGD:1319303 6480464 Benzo(a)pyrene results in increased expression of PPP1R3C mRNA CTD PMID:19770486 benzo[a]pyrene diol epoxide I increases expression ISO RGD:1319302 6480464 7 more ... CTD PMID:19150397 benzo[b]fluoranthene decreases expression ISO RGD:1319303 6480464 benzo(b)fluoranthene results in decreased expression of PPP1R3C mRNA CTD PMID:26377693 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1319302 6480464 Diethylhexyl Phthalate results in decreased expression of PPP1R3C mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of PPP1R3C mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1319303 6480464 bisphenol A results in decreased expression of PPP1R3C mRNA CTD PMID:34585602 bisphenol A multiple interactions ISO RGD:1319303 6480464 [bisphenol A co-treated with Tretinoin] results in increased expression of PPP1R3C mRNA CTD PMID:30951980 bisphenol A affects expression ISO RGD:1319302 6480464 bisphenol A affects the expression of PPP1R3C mRNA CTD PMID:30903817 bisphenol A increases expression ISO RGD:1319302 6480464 bisphenol A results in increased expression of PPP1R3C mRNA CTD PMID:29275510 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPP1R3C mRNA CTD PMID:30816183 more ... bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of PPP1R3C mRNA CTD PMID:25181051 bisphenol F increases expression ISO RGD:1319303 6480464 bisphenol F results in increased expression of PPP1R3C mRNA CTD PMID:30951980 cannabidiol increases expression ISO RGD:1319302 6480464 Cannabidiol results in increased expression of PPP1R3C mRNA CTD PMID:26504004 carbon nanotube affects expression ISO RGD:1319303 6480464 Nanotubes, Carbon affects the expression of PPP1R3C mRNA CTD PMID:25554681 carbon nanotube increases expression ISO RGD:1319303 6480464 Nanotubes, Carbon results in increased expression of PPP1R3C mRNA CTD PMID:25620056 carbon nanotube decreases expression ISO RGD:1319303 6480464 Nanotubes, Carbon analog results in decreased expression of PPP1R3C mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1319302 6480464 CGP 52608 promotes the reaction [RORA protein binds to PPP1R3C gene] CTD PMID:28238834 chenodeoxycholic acid multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA more ... CTD PMID:33819548 chlordecone increases expression ISO RGD:1319303 6480464 Chlordecone results in increased expression of PPP1R3C mRNA CTD PMID:33711761 chloropicrin increases expression ISO RGD:1319302 6480464 chloropicrin results in increased expression of PPP1R3C mRNA CTD PMID:26352163 chloroprene decreases expression ISO RGD:1319303 6480464 Chloroprene results in decreased expression of PPP1R3C mRNA CTD PMID:23125180 chlorpyrifos increases methylation EXP 6480464 Chlorpyrifos results in increased methylation of PPP1R3C gene CTD PMID:32905263 choline multiple interactions ISO RGD:1319303 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R3C mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1319302 6480464 Cisplatin results in increased expression of PPP1R3C mRNA CTD PMID:27392435 clobetasol increases expression ISO RGD:1319303 6480464 Clobetasol results in increased expression of PPP1R3C mRNA CTD PMID:27462272 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PPP1R3C mRNA CTD PMID:17602206 clothianidin increases expression ISO RGD:1319302 6480464 clothianidin results in increased expression of PPP1R3C mRNA CTD PMID:29044138 cobalt atom multiple interactions ISO RGD:1319302 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of PPP1R3C mRNA CTD PMID:20105288 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of PPP1R3C mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1319302 6480464 cobaltous chloride results in increased expression of PPP1R3C mRNA CTD PMID:19376846 , PMID:20105288 copper atom multiple interactions ISO RGD:1319302 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R3C mRNA CTD PMID:24690739 copper(0) multiple interactions ISO RGD:1319302 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R3C mRNA CTD PMID:24690739 copper(II) sulfate decreases expression ISO RGD:1319302 6480464 Copper Sulfate results in decreased expression of PPP1R3C mRNA CTD PMID:19549813 crocidolite asbestos decreases expression ISO RGD:1319302 6480464 Asbestos, Crocidolite results in decreased expression of PPP1R3C mRNA CTD PMID:25351596 cyclosporin A decreases expression ISO RGD:1319303 6480464 Cyclosporine results in decreased expression of PPP1R3C mRNA CTD PMID:19770486 cyclosporin A multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 cyclosporin A decreases expression ISO RGD:1319302 6480464 Cyclosporine results in decreased expression of PPP1R3C mRNA CTD PMID:20106945 , PMID:25562108 cyclosporin A increases expression ISO RGD:1319303 6480464 Cyclosporine results in increased expression of PPP1R3C mRNA CTD PMID:25270620 deoxycholic acid multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA more ... CTD PMID:33819548 dexamethasone decreases expression ISO RGD:1319302 6480464 Dexamethasone results in decreased expression of PPP1R3C mRNA CTD PMID:25047013 dibenz[a,h]anthracene decreases expression ISO RGD:1319303 6480464 1 more ... CTD PMID:26377693 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of PPP1R3C mRNA CTD PMID:21161181 dioxygen increases expression ISO RGD:1319303 6480464 Oxygen deficiency results in increased expression of PPP1R3C mRNA CTD PMID:20880076 dioxygen multiple interactions ISO RGD:1319303 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of PPP1R3C mRNA CTD PMID:30529165 dioxygen increases expression ISO RGD:1319302 6480464 Oxygen deficiency results in increased expression of PPP1R3C mRNA CTD PMID:20042640 , PMID:26516004 disulfiram multiple interactions ISO RGD:1319302 6480464 [Disulfiram binds to Copper] which results in decreased expression of PPP1R3C mRNA CTD PMID:24690739 diuron decreases expression EXP 6480464 Diuron results in decreased expression of PPP1R3C mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:1319302 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R3C mRNA CTD PMID:27188386 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of PPP1R3C mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1319302 6480464 entinostat results in increased expression of PPP1R3C mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1319303 6480464 epoxiconazole results in increased expression of PPP1R3C mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1319303 6480464 Ethanol affects the expression of PPP1R3C mRNA CTD PMID:30319688 ethanol increases expression ISO RGD:1319303 6480464 Ethanol results in increased expression of PPP1R3C mRNA CTD PMID:30319688 folic acid multiple interactions ISO RGD:1319303 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R3C mRNA CTD PMID:20938992 formaldehyde decreases expression ISO RGD:1319302 6480464 Formaldehyde results in decreased expression of PPP1R3C mRNA CTD PMID:27905399 furan increases methylation EXP 6480464 furan results in increased methylation of PPP1R3C gene CTD PMID:22079235 genistein decreases expression ISO RGD:1319302 6480464 Genistein results in decreased expression of PPP1R3C mRNA CTD PMID:22228119 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of PPP1R3C mRNA CTD PMID:20621112 glycochenodeoxycholic acid multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA more ... CTD PMID:33819548 GW 4064 decreases expression ISO RGD:1319303 6480464 GW 4064 results in decreased expression of PPP1R3C mRNA CTD PMID:26655953 hydrogen peroxide affects expression ISO RGD:1319302 6480464 Hydrogen Peroxide affects the expression of PPP1R3C mRNA CTD PMID:23410634 imiquimod multiple interactions ISO RGD:1319303 6480464 [resveratrol co-treated with imiquimod] results in decreased expression of PPP1R3C mRNA CTD PMID:25965695 L-methionine multiple interactions ISO RGD:1319303 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of PPP1R3C mRNA CTD PMID:20938992 lead(0) affects expression ISO RGD:1319302 6480464 Lead affects the expression of PPP1R3C mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1319302 6480464 Lead affects the expression of PPP1R3C mRNA CTD PMID:28903495 menadione affects expression ISO RGD:1319302 6480464 Vitamin K 3 affects the expression of PPP1R3C mRNA CTD PMID:23410634 metformin increases expression EXP 6480464 Metformin results in increased expression of PPP1R3C mRNA CTD PMID:31324951 methotrexate affects expression ISO RGD:1319303 6480464 Methotrexate affects the expression of PPP1R3C mRNA CTD PMID:18502557 methotrexate increases expression ISO RGD:1319302 6480464 Methotrexate results in increased expression of PPP1R3C mRNA CTD PMID:24449571 methylisothiazolinone increases expression ISO RGD:1319302 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of PPP1R3C mRNA CTD PMID:31629900 methylmercury chloride increases expression ISO RGD:1319302 6480464 methylmercuric chloride results in increased expression of PPP1R3C mRNA CTD PMID:28001369 methylparaben increases expression ISO RGD:1319302 6480464 methylparaben results in increased expression of PPP1R3C mRNA CTD PMID:31745603 miconazole increases expression ISO RGD:1319303 6480464 Miconazole results in increased expression of PPP1R3C mRNA CTD PMID:27462272 N-ethyl-N-nitrosourea increases expression ISO RGD:1319303 6480464 Ethylnitrosourea results in increased expression of PPP1R3C mRNA CTD PMID:19100860 N-nitrosodiethylamine increases expression ISO RGD:1319303 6480464 Diethylnitrosamine results in increased expression of PPP1R3C mRNA CTD PMID:19100860 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of PPP1R3C mRNA CTD PMID:17602206 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of PPP1R3C mRNA CTD PMID:25380136 nefazodone multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 nickel atom increases expression ISO RGD:1319302 6480464 Nickel results in increased expression of PPP1R3C mRNA CTD PMID:25583101 nickel dichloride increases expression ISO RGD:1319302 6480464 nickel chloride results in increased expression of PPP1R3C mRNA CTD PMID:21455298 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of PPP1R3C mRNA CTD PMID:22110744 nimesulide decreases expression EXP 6480464 nimesulide results in decreased expression of PPP1R3C mRNA CTD PMID:24136188 obeticholic acid decreases expression ISO RGD:1319302 6480464 obeticholic acid results in decreased expression of PPP1R3C mRNA CTD PMID:27939613 p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of PPP1R3C mRNA CTD PMID:27638505 paracetamol affects expression ISO RGD:1319303 6480464 Acetaminophen affects the expression of PPP1R3C mRNA CTD PMID:15606129 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PPP1R3C mRNA CTD PMID:33387578 paracetamol multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in increased expression of PPP1R3C mRNA CTD PMID:33819548 paracetamol increases expression ISO RGD:1319302 6480464 Acetaminophen results in increased expression of PPP1R3C mRNA CTD PMID:21420995 paraquat increases expression ISO RGD:1319303 6480464 Paraquat results in increased expression of PPP1R3C mRNA CTD PMID:21463325 parathion decreases expression ISO RGD:1319303 6480464 Parathion results in decreased expression of PPP1R3C mRNA CTD PMID:34813904 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1319303 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of PPP1R3C mRNA, [perfluorooctane sulfonic acid co-treated with Pectins] results in decreased expression of PPP1R3C mRNA CTD PMID:36331819 phenobarbital increases expression ISO RGD:1319303 6480464 Phenobarbital results in increased expression of PPP1R3C mRNA CTD PMID:19270015 phenylmercury acetate decreases expression ISO RGD:1319302 6480464 Phenylmercuric Acetate results in decreased expression of PPP1R3C mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1319302 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R3C mRNA CTD PMID:27188386 pioglitazone multiple interactions ISO RGD:1319303 6480464 [N-nitroso-tris-chloroethylurea co-treated with pioglitazone] results in decreased expression of PPP1R3C mRNA CTD PMID:27935865 pirinixic acid decreases expression ISO RGD:1319303 6480464 pirinixic acid results in decreased expression of PPP1R3C mRNA CTD PMID:20813756 pirinixic acid increases expression ISO RGD:1319303 6480464 pirinixic acid results in increased expression of PPP1R3C mRNA CTD PMID:18445702 pirinixic acid multiple interactions ISO RGD:1319303 6480464 [pirinixic acid co-treated with PPARA] results in decreased expression of PPP1R3C mRNA CTD PMID:20813756 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:1319303 6480464 Pregnenolone Carbonitrile results in decreased expression of PPP1R3C mRNA CTD PMID:28903501 propiconazole decreases expression ISO RGD:1319303 6480464 propiconazole results in decreased expression of PPP1R3C mRNA CTD PMID:21278054 quercetin decreases expression ISO RGD:1319302 6480464 Quercetin results in decreased expression of PPP1R3C mRNA CTD PMID:21632981 quinolin-8-ol decreases expression ISO RGD:1319302 6480464 Oxyquinoline results in decreased expression of PPP1R3C mRNA CTD PMID:21632981 rac-lactic acid decreases expression ISO RGD:1319302 6480464 Lactic Acid results in decreased expression of PPP1R3C mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1319303 6480464 [resveratrol co-treated with imiquimod] results in decreased expression of PPP1R3C mRNA CTD PMID:25965695 rotenone decreases expression ISO RGD:1319303 6480464 Rotenone results in decreased expression of PPP1R3C mRNA CTD PMID:23186747 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1319302 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of PPP1R3C mRNA CTD PMID:33725128 SB 431542 multiple interactions ISO RGD:1319302 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PPP1R3C mRNA CTD PMID:27188386 silicon dioxide decreases expression ISO RGD:1319302 6480464 Silicon Dioxide analog results in decreased expression of PPP1R3C mRNA, Silicon Dioxide results in decreased expression of PPP1R3C mRNA CTD PMID:25351596 , PMID:25895662 silver atom increases expression ISO RGD:1319302 6480464 Silver results in increased expression of PPP1R3C mRNA CTD PMID:26551752 silver(0) increases expression ISO RGD:1319302 6480464 Silver results in increased expression of PPP1R3C mRNA CTD PMID:26551752 Soman increases expression EXP 6480464 Soman results in increased expression of PPP1R3C mRNA CTD PMID:19281266 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PPP1R3C mRNA CTD PMID:25905778 sulforaphane decreases expression ISO RGD:1319302 6480464 sulforaphane results in decreased expression of PPP1R3C mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:1319302 6480464 Sunitinib results in increased expression of PPP1R3C mRNA CTD PMID:31533062 tamoxifen affects expression ISO RGD:1319303 6480464 Tamoxifen affects the expression of PPP1R3C mRNA CTD PMID:20937368 tartrazine multiple interactions ISO RGD:1319302 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in decreased expression of PPP1R3C mRNA CTD PMID:33819548 tert-butyl hydroperoxide decreases expression ISO RGD:1319302 6480464 tert-Butylhydroperoxide results in decreased expression of PPP1R3C mRNA CTD PMID:15336504 tert-butyl hydroperoxide affects expression ISO RGD:1319302 6480464 tert-Butylhydroperoxide affects the expression of PPP1R3C mRNA CTD PMID:23410634 testosterone increases expression ISO RGD:1319303 6480464 Testosterone results in increased expression of PPP1R3C mRNA CTD PMID:20403060 testosterone decreases expression ISO RGD:1319302 6480464 Testosterone results in decreased expression of PPP1R3C mRNA CTD PMID:33359661 tetrachloromethane decreases expression ISO RGD:1319303 6480464 Carbon Tetrachloride results in decreased expression of PPP1R3C mRNA CTD PMID:31919559 tetracycline increases expression ISO RGD:1319303 6480464 Tetracycline results in increased expression of PPP1R3C mRNA CTD PMID:16917069 tetraphene decreases expression ISO RGD:1319303 6480464 benz(a)anthracene results in decreased expression of PPP1R3C mRNA CTD PMID:26377693 thapsigargin decreases expression ISO RGD:1319302 6480464 Thapsigargin results in decreased expression of PPP1R3C mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of PPP1R3C mRNA CTD PMID:23411599 , PMID:34492290 titanium dioxide decreases expression ISO RGD:1319303 6480464 titanium dioxide results in decreased expression of PPP1R3C mRNA CTD PMID:27760801 tremolite asbestos increases expression ISO RGD:1319303 6480464 tremolite results in increased expression of PPP1R3C mRNA CTD PMID:29279043 tributylstannane decreases expression ISO RGD:1319303 6480464 tributyltin results in decreased expression of PPP1R3C mRNA CTD PMID:31939706 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPP1R3C mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO RGD:1319302 6480464 [[decitabine co-treated with trichostatin A] affects the methylation of PPP1R3C promoter] which affects the expression of PPP1R3C mRNA CTD PMID:18803327 trichostatin A increases expression ISO RGD:1319302 6480464 trichostatin A results in increased expression of PPP1R3C mRNA CTD PMID:24935251 triclosan decreases expression ISO RGD:1319302 6480464 Triclosan results in decreased expression of PPP1R3C mRNA CTD PMID:30510588 trimellitic anhydride decreases expression ISO RGD:1319303 6480464 trimellitic anhydride results in decreased expression of PPP1R3C mRNA CTD PMID:19042947 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of PPP1R3C mRNA CTD PMID:30589522 Triptolide increases expression EXP 6480464 triptolide results in increased expression of PPP1R3C mRNA CTD PMID:23639586 triptonide increases expression ISO RGD:1319303 6480464 triptonide results in increased expression of PPP1R3C mRNA CTD PMID:33045310 Tungsten carbide multiple interactions ISO RGD:1319302 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of PPP1R3C mRNA CTD PMID:20105288 tunicamycin decreases expression ISO RGD:1319302 6480464 Tunicamycin results in decreased expression of PPP1R3C mRNA CTD PMID:22378314 valproic acid affects expression ISO RGD:1319302 6480464 Valproic Acid affects the expression of PPP1R3C mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1319302 6480464 Valproic Acid results in decreased expression of PPP1R3C mRNA CTD PMID:29154799 valproic acid increases expression ISO RGD:1319302 6480464 Valproic Acid results in increased expression of PPP1R3C mRNA CTD PMID:24383497 more ... valsartan multiple interactions ISO RGD:1319302 6480464 Valsartan inhibits the reaction [AGT protein results in decreased expression of PPP1R3C mRNA] CTD PMID:19225232 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of PPP1R3C mRNA CTD PMID:20566332 vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of PPP1R3C mRNA CTD PMID:19015723 zinc sulfate increases expression ISO RGD:1319302 6480464 Zinc Sulfate results in increased expression of PPP1R3C mRNA CTD PMID:16330358